LGMD2E
In 2018 the first clinical trial of gene therapy for LGMD2E started in the United States.
Gene Delivery Clinical Trial of SRP-9003 for Patients With LGMD2E (Beta-sarcoglycan Deficiency)
LGMD2D
On 2013 a gene therapy clinical trial for LGMD2D started in the United States carried out by dr. Jerry Mendell.
Gene Transfer Clinical Trial for LGMD2D (Alpha-sarcoglycan Deficiency) Using scAAVrh74.tMCK.hSGCA
LGMD2C
In 2011, a gene therapy clinical trial was carried out in France for LGMD2C by dr. Serge Herson.
Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C
On 2007, a gene therapy clinical trial was carried out in the United States by Dr. Jerry Mendell
Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)
15 October 2020 | Clinical trials
SRP-9003 Gene Therapy for LGMD2E Shows Benefit after 1 year - Muscular Dystrophy News Today - June 9 2020
https://musculardystrophynews.com/2020/06/09/srp-9003-gene-therapy-continues-significant-benefits-children-lgmd2e-phase-1-2-trial/?fbclid=IwAR14O20MUNtLs2wuIwz2oH4CVZivqhmP4IC3ExbKXsZmJXr1H3n6C9Fd4MY
New data gives hope for Limb Girdle Muscular Dystrophy gene therapy - Patient Worthy - June 17, 2020
https://patientworthy.com/2020/06/17/data-gives-hope-limb-girdle-muscular-dystrophy/
31 December 2019 | Clinical trials
SRP-9003 gene therapy shows "very encouraging" results at 9 months in girdle dystrophy - Sarepta Reports - october 9 2019
https://musculardystrophynews.com/2019/10/09/srp-9003-lgmd-2e-gene-therapy-shows-encouraging-9-month-results-sarepta-reports/?fbclid=IwAR2eeni-mgYqgcTPkfFT8aTXsRg6I0WAymm6OENZvBM098ozSKo70btfZ3Q
Myonexus Therapeutics announced the initiation of a trial for the first-ever Gene Therapy for Beta-Sarcoglycanopathy
https://www.businesswire.com/news/home/20181108005462/en/Myonexus-Therapeutics-Announces-Initiation-Trial-First-Ever-Gene?fbclid=IwAR2PCw6Z4WCD2WCJjuD9MwrIbHaysdXpd-WfVZzy5Kt3Mdz9QO2Q7vugv2k
©2020 GFBONLUS.IT - GRUPPO FAMILIARI BETA-SARCOGLICANOPATIE +39 328 0075986 This email address is being protected from spambots. You need JavaScript enabled to view it.
Via Civasca 112 23018 Talamona - SO Italia
Made by Betsoft
